Skip to main content

Palo Alto Investors LP

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1306923 PALO ALTO, CA

Position in ACAD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$63,946,190
-$2,402,278 QoQ
Shares Held
2,872,695
+15.6% QoQ
Ownership
1.68%
of shares outstanding
% of Portfolio
9.78%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Palo Alto Investors LP holds $542,554,052 across 38 Biotechnology names. ACAD ranks #2 (11.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ACAD
Acadia Pharmaceuticals Inc
This page
2,872,695 $63,946,190

All Filings in ACAD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $63,946,190 2,872,695
2025-12-31 $66,348,468 2,484,031
2025-09-30 $52,639,036 2,466,684
2025-06-30 $55,288,418 2,563,209
2025-03-31 $44,247,794 2,663,925
2024-12-31 $50,436,791 2,748,599
2024-09-30 $38,818,443 2,523,956
2024-06-30 $39,306,166 2,418,841
2024-03-31 $44,652,296 2,414,943
2023-12-31 $75,443,198 2,409,556
2023-09-30 $50,136,726 2,405,793
2023-06-30 $57,618,742 2,405,793
2023-03-31 $45,277,024 2,405,793
2022-12-31 $37,831,794 2,376,369
2022-09-30 $27,455,286 1,678,196
2022-06-30 $23,645,781 1,678,196
2022-03-31 $54,539,419 2,251,834
2021-12-31 $54,566,049 2,337,877
2021-09-30 $38,832,136 2,337,877
2021-06-30 $57,020,820 2,337,877
2021-03-31 $60,317,226 2,337,877
2020-12-31 $123,036,960 2,301,477
2020-09-30 $75,582,375 1,832,300
2020-06-30 $75,850,703 1,564,900
2020-03-31 $68,931,889 1,631,524